Nutrien (NYSE:NTR – Get Free Report) had its price objective lowered by investment analysts at BMO Capital Markets from $80.00 to $75.00 in a report issued on Friday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. BMO Capital Markets’ price target points to a potential upside of 63.26% from the company’s current price.
Several other analysts also recently weighed in on the company. Piper Sandler decreased their target price on Nutrien from $56.00 to $55.00 and set an “underweight” rating for the company in a research report on Tuesday, June 11th. Berenberg Bank upgraded shares of Nutrien from a “hold” rating to a “buy” rating and lifted their price objective for the company from $60.00 to $66.00 in a report on Monday, April 29th. Royal Bank of Canada dropped their target price on shares of Nutrien from $70.00 to $60.00 and set an “outperform” rating on the stock in a research note on Monday, July 15th. Wells Fargo & Company decreased their price target on shares of Nutrien from $68.00 to $66.00 and set an “overweight” rating for the company in a research note on Tuesday, July 16th. Finally, Scotiabank dropped their price objective on Nutrien from $67.00 to $66.00 and set an “outperform” rating on the stock in a research note on Monday, May 13th. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, Nutrien presently has a consensus rating of “Moderate Buy” and a consensus price target of $64.89.
Check Out Our Latest Research Report on Nutrien
Nutrien Price Performance
Nutrien (NYSE:NTR – Get Free Report) last released its earnings results on Wednesday, August 7th. The company reported $2.34 earnings per share for the quarter, beating the consensus estimate of $2.19 by $0.15. The firm had revenue of $10.16 billion for the quarter, compared to the consensus estimate of $10.82 billion. Nutrien had a return on equity of 7.31% and a net margin of 3.01%. The company’s revenue for the quarter was down 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.53 EPS. Equities analysts forecast that Nutrien will post 3.78 earnings per share for the current year.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. International Assets Investment Management LLC purchased a new stake in shares of Nutrien in the fourth quarter worth about $3,433,000. Prime Capital Investment Advisors LLC acquired a new position in shares of Nutrien in the 4th quarter valued at $230,000. Bleakley Financial Group LLC boosted its holdings in Nutrien by 14.8% during the fourth quarter. Bleakley Financial Group LLC now owns 6,109 shares of the company’s stock worth $344,000 after buying an additional 786 shares in the last quarter. Allspring Global Investments Holdings LLC purchased a new stake in Nutrien during the fourth quarter worth $61,000. Finally, Cerity Partners LLC purchased a new position in Nutrien in the fourth quarter valued at $437,000. 63.10% of the stock is currently owned by institutional investors and hedge funds.
Nutrien Company Profile
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
See Also
- Five stocks we like better than Nutrien
- Insider Buying Explained: What Investors Need to Know
- Why Wall Street Analysts Raised Price Targets for Suncor Stock
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Is Super Micro Computer a Buy After Shares Sink 20% on Earnings?
- Options Trading – Understanding Strike Price
- MarketBeat Week in Review – 8/5 – 8/9
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.